BSE filing, NSE: LICI. Summary written from the filing by ALFA Finder's alert engine.
Life Insurance Corporation of India: key numbers
- Share price
- ₹391.45
- Market cap
- ₹4,95,184 Cr
- Revenue (annual)
- ₹9,77,772 Cr
- Net profit (annual)
- ₹57,453 Cr
- P/E (TTM)
- 8.2×Sector 19.7×
- Promoter holding
- 90.00%-6.50% QoQ
- FII holding
- 1.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Life Insurance Corporation of India
All →Life Insurance Corporation of India Board Meeting Date
LIC intimated that its Board is scheduled for 05 Nov 2026 to approve Q2 and half-year financial results. Trading window for insiders is closed from 01 Oct 2026 until 48 hours post-meeting.
Life Insurance Corporation of India Product Launch
Life Insurance Corporation of India is launching three new insurance products—LIC's New Jeevan Dhara-II, Health Shield, and New Cancer Cover—effective October 19, 2026.
Life Insurance Corporation of India Management Change
LIC has appointed five new Independent Directors, including Shailesh Kumar Singh and David Paul Rasquinha, for a term of four years effective October 07, 2026.
Life Insurance Corporation of India Management Change
Life Insurance Corporation of India announced the voluntary retirement of Shri Dinesh Pant as Managing Director. He ceased to be a Key Managerial Personnel on September 24, 2026.
Life Insurance Corporation of India Product Launch
Life Insurance Corporation of India is launching two new individual insurance products, LIC’s Bima Platinum and LIC’s Jeevan Raksha. Both products will be available for sale from September 7, 2026.
Life Insurance Corporation of India Management Change
Life Insurance Corporation of India announced the superannuation of Shri Sesha Giridhar Kuppili. He served as Executive Director (Pension & Group Schemes) until August 31, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.